Practical demonstration of the LumiraDx testing device

Tutorial provided by LumeraDx.


The LumiraDx SARS-CoV-2 Ag Test is designed to be used in health care settings to provide an aid to rapid diagnosis of COVID-19. The test uses a nasal swab specimen from individuals at risk of, or with symptoms of, COVID-19 within the first 12 days of symptom onset.

Welsh Government has purchased 400 LumiraDx Point-of-Care devices with several hundred thousand testing strips to support rapid COVID testing for selected patients with symptoms. The devices provide a rapid test for COVID-19, generating an infection status in approximately 12 minutes (start to finish is 20 minutes).

Mark as Understood

Resources

LumeraDx Quick Reference Guide

LumeraDx Test Specifications

LumeraDx Product Insert

LumeraDx Quality Controls

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk